Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) [Phase 2]
Phase 2 clinical trial update on Zevalin-containing nonmyeloablative conditioning for stem cell transplantation in leukemia and lymphoma; re…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies [Phase 2]
Phase 2 trial evaluating Thiotepa-Clofarabine-Busulfan conditioning with allogeneic stem cell transplant for high-risk malignancies has comp…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without rituximab in lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy in treating young patients with Hodgkin's lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated durvalumab as monotherapy and in combination therapy for lymphoma and chronic lymphocytic leukemia, and…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation [Phase 2]
Phase 2 trial evaluating autologous CMV-specific cytotoxic T cells for CMV reactivation in leukemia and lymphoma patients has completed with…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab [Phase 1]
Phase 1 study of PF-05082566 as a single agent and with rituximab in various lymphomas; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Phase II Study of TAK228 in Relapsed Lymphoma [Phase 1, Phase 2]
Phase II study of TAK228 in relapsed lymphoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases [Phase 2]
Phase 2 trial investigating pemetrexed disodium for recurrent malignant gliomas, primary CNS lymphoma, or brain metastases; status is unknow…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 [Phase 2]
Phase 2 clinical trial update on rasburicase for patients at high risk of tumor lysis syndrome during cycle 2; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan [Phase 3]
Phase 3 trial update evaluating equivalence in pharmacokinetics and noninferiority of efficacy for CT-P10 versus Rituxan in lymphoma (follic…
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage [Phase 2]
Phase 2 trial comparing PEG-ASP+Gemoxd versus PEG-ASP+CHOP as first-line chemotherapy for early-stage NK/T-cell lymphoma; status and results…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Aza-SAHA-GBM with autologous stem cell transplant for refractory lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy [Phase 1, Phase 2]
Phase I/II study evaluating mis-matched immune cells (AlloStim) in patients with advanced hematological malignancies; trial completed.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]
Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunot…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma [NA]
Clinical trial update for TCR-α/β and CD19 depleted stem cell grafts from haplo donors in relapsed lymphoma; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating co-treatment with GnRH analogs to protect ovarian reserve in young women receiving alkylating chemotherap…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease [Phase 2]
Phase 2 trial of high-dose gemcitabine, busulfan, and melphalan for patients with refractory Hodgkin's lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype [Phase 1, Phase 2]
Phase 1/2 study evaluating lenalidomide with vorinostat, gemcitabine, busulfan, and melphalan with autologous stem-cell transplantation in d…
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Tenofovir to Prevent HBV Reactivation [Phase 3]
Phase 3 clinical trial update on using tenofovir to prevent hepatitis B reactivation in patients with hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.